Letter to the editor: radiomics signature for dynamic monitoring of tumor-inflamed microenvironment and immunotherapy response prediction

We read with great interest the article by Bernatowicz et al. Despite the promising findings, we would like to highlight several concerns regarding the methodology and interpretation of the results that warrant further discussion, including the stability of radiomic features across pan-cancer types,...

Full description

Saved in:
Bibliographic Details
Main Authors: Shuixing Zhang, Yuhao Dong
Format: Article
Language:English
Published: BMJ Publishing Group 2025-02-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/13/2/e011778.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850043699804766208
author Shuixing Zhang
Yuhao Dong
author_facet Shuixing Zhang
Yuhao Dong
author_sort Shuixing Zhang
collection DOAJ
description We read with great interest the article by Bernatowicz et al. Despite the promising findings, we would like to highlight several concerns regarding the methodology and interpretation of the results that warrant further discussion, including the stability of radiomic features across pan-cancer types, the optimal threshold for CT-TIME (tumor immune microenvironment) scores, the biological interpretability of radiomic models, and the survival tail effect of immunotherapy responses.
format Article
id doaj-art-3c81d302814c4e5d8b932a55b6fa7073
institution DOAJ
issn 2051-1426
language English
publishDate 2025-02-01
publisher BMJ Publishing Group
record_format Article
series Journal for ImmunoTherapy of Cancer
spelling doaj-art-3c81d302814c4e5d8b932a55b6fa70732025-08-20T02:55:10ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262025-02-0113210.1136/jitc-2025-011778Letter to the editor: radiomics signature for dynamic monitoring of tumor-inflamed microenvironment and immunotherapy response predictionShuixing Zhang0Yuhao Dong1Radiology, Jinan University First Affiliated Hospital, Guangzhou, Guangdong, ChinaRadiology, Jinan University First Affiliated Hospital, Guangzhou, Guangdong, ChinaWe read with great interest the article by Bernatowicz et al. Despite the promising findings, we would like to highlight several concerns regarding the methodology and interpretation of the results that warrant further discussion, including the stability of radiomic features across pan-cancer types, the optimal threshold for CT-TIME (tumor immune microenvironment) scores, the biological interpretability of radiomic models, and the survival tail effect of immunotherapy responses.https://jitc.bmj.com/content/13/2/e011778.full
spellingShingle Shuixing Zhang
Yuhao Dong
Letter to the editor: radiomics signature for dynamic monitoring of tumor-inflamed microenvironment and immunotherapy response prediction
Journal for ImmunoTherapy of Cancer
title Letter to the editor: radiomics signature for dynamic monitoring of tumor-inflamed microenvironment and immunotherapy response prediction
title_full Letter to the editor: radiomics signature for dynamic monitoring of tumor-inflamed microenvironment and immunotherapy response prediction
title_fullStr Letter to the editor: radiomics signature for dynamic monitoring of tumor-inflamed microenvironment and immunotherapy response prediction
title_full_unstemmed Letter to the editor: radiomics signature for dynamic monitoring of tumor-inflamed microenvironment and immunotherapy response prediction
title_short Letter to the editor: radiomics signature for dynamic monitoring of tumor-inflamed microenvironment and immunotherapy response prediction
title_sort letter to the editor radiomics signature for dynamic monitoring of tumor inflamed microenvironment and immunotherapy response prediction
url https://jitc.bmj.com/content/13/2/e011778.full
work_keys_str_mv AT shuixingzhang lettertotheeditorradiomicssignaturefordynamicmonitoringoftumorinflamedmicroenvironmentandimmunotherapyresponseprediction
AT yuhaodong lettertotheeditorradiomicssignaturefordynamicmonitoringoftumorinflamedmicroenvironmentandimmunotherapyresponseprediction